
New study by @MananPareekMD and colleagues from @CTCPR_ , published in @JACCJournals.
Key takeaways:
• High-dose influenza vaccine provided consistent protection in older adults with and without ASCVD.
• Benefits were similar across ASCVD subtypes.
• Patients with ASCVD had greater absolute benefit due to their higher baseline risk.
These findings strengthen the case for prioritizing high-dose influenza vaccination in older adults, particularly those with established cardiovascular disease.
Full study link: sciencedirect.com/science/articl…
@TorBiering
@CopCard
@RigsHeart
@HGHHjerte
@Stenodiabetes
@niklasdj1
@RebeccaCHarris

English

























